EP3436605A4 - Amplification de séquences cibles - Google Patents

Amplification de séquences cibles Download PDF

Info

Publication number
EP3436605A4
EP3436605A4 EP17772883.9A EP17772883A EP3436605A4 EP 3436605 A4 EP3436605 A4 EP 3436605A4 EP 17772883 A EP17772883 A EP 17772883A EP 3436605 A4 EP3436605 A4 EP 3436605A4
Authority
EP
European Patent Office
Prior art keywords
amplification
target sequences
sequences
target
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP17772883.9A
Other languages
German (de)
English (en)
Other versions
EP3436605A1 (fr
Inventor
Melinda JASPER
Michelle FRASER
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Revvity Holdings Inc
Original Assignee
PerkinElmer Health Sciences Australia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2016901197A external-priority patent/AU2016901197A0/en
Application filed by PerkinElmer Health Sciences Australia Pty Ltd filed Critical PerkinElmer Health Sciences Australia Pty Ltd
Publication of EP3436605A1 publication Critical patent/EP3436605A1/fr
Publication of EP3436605A4 publication Critical patent/EP3436605A4/fr
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP17772883.9A 2016-03-31 2017-03-31 Amplification de séquences cibles Pending EP3436605A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2016901197A AU2016901197A0 (en) 2016-03-31 Amplification of Target Sequences
PCT/AU2017/050281 WO2017165925A1 (fr) 2016-03-31 2017-03-31 Amplification de séquences cibles

Publications (2)

Publication Number Publication Date
EP3436605A1 EP3436605A1 (fr) 2019-02-06
EP3436605A4 true EP3436605A4 (fr) 2019-08-21

Family

ID=59962297

Family Applications (1)

Application Number Title Priority Date Filing Date
EP17772883.9A Pending EP3436605A4 (fr) 2016-03-31 2017-03-31 Amplification de séquences cibles

Country Status (5)

Country Link
US (1) US20190345538A1 (fr)
EP (1) EP3436605A4 (fr)
CN (1) CN109312395A (fr)
WO (1) WO2017165925A1 (fr)
ZA (1) ZA201807215B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019359771A1 (en) * 2018-10-17 2021-05-06 Revvity Holdings, Inc. Barcoding of nucleic acids
CN113166757A (zh) * 2019-02-15 2021-07-23 宝生物工程（美国)有限公司 核酸文库的制备和分析方法
CN111621555A (zh) * 2019-06-13 2020-09-04 中国科学院广州生物医药与健康研究院 生物标志物及其应用
BR112022000722A2 (pt) * 2019-07-16 2022-03-08 Meliolabs Inc Métodos e dispositivos para curva de melting digital baseada em célula única
WO2023137313A2 (fr) * 2022-01-14 2023-07-20 Abs Global, Inc. Adn libre circulant destiné à être utilisé dans le génotypage
CN115725694A (zh) * 2022-11-14 2023-03-03 中国农业科学院深圳农业基因组研究所 一种对基因组的一部分进行富集的方法与相关应用
CN115961007A (zh) * 2022-11-14 2023-04-14 中国农业科学院农业基因组研究所 一种利用简并引物扩增进行全基因组分子标记开发的方法
CN117402961B (zh) * 2023-12-13 2024-03-12 北京华宇亿康生物工程技术有限公司 一种胚胎植入前染色体非整倍体快速检测的引物、试剂盒和方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009105531A1 (fr) * 2008-02-19 2009-08-27 Gene Security Network, Inc. Procédés de génotypage cellulaire
WO2011131192A1 (fr) * 2010-04-22 2011-10-27 Statens Serum Institut Nouveau procédé d'amplification de séquences nucléotidiques
EP2660331A1 (fr) * 2010-12-31 2013-11-06 BGI Shenzhen Co., Limited Procédé pour l'analyse de génome de cellule unique et trousse correspondante
US9249459B2 (en) * 2009-01-13 2016-02-02 Fluidigm Corporation Single cell nucleic acid analysis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994058A (en) * 1995-03-20 1999-11-30 Genome International Corporation Method for contiguous genome sequencing
EP1672080A1 (fr) * 2004-12-14 2006-06-21 Institut National De La Sante Et De La Recherche Medicale (Inserm) Méthode PCR universelle
US8192940B2 (en) * 2006-05-04 2012-06-05 Seegene, Inc. Method for amplifying unknown DNA sequence adjacent to known sequence
WO2008051928A2 (fr) * 2006-10-23 2008-05-02 The Salk Institute For Biological Studies Amplification ciblée d'un génome entier d'acides nucléiques

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009105531A1 (fr) * 2008-02-19 2009-08-27 Gene Security Network, Inc. Procédés de génotypage cellulaire
US9249459B2 (en) * 2009-01-13 2016-02-02 Fluidigm Corporation Single cell nucleic acid analysis
WO2011131192A1 (fr) * 2010-04-22 2011-10-27 Statens Serum Institut Nouveau procédé d'amplification de séquences nucléotidiques
EP2660331A1 (fr) * 2010-12-31 2013-11-06 BGI Shenzhen Co., Limited Procédé pour l'analyse de génome de cellule unique et trousse correspondante

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2017165925A1 *

Also Published As

Publication number Publication date
EP3436605A1 (fr) 2019-02-06
CN109312395A (zh) 2019-02-05
US20190345538A1 (en) 2019-11-14
ZA201807215B (en) 2020-01-29
WO2017165925A1 (fr) 2017-10-05

Similar Documents

Publication Publication Date Title
EP3436581A4 (fr) Procédés d'amplification de transcriptome entier
EP3551169A4 (fr) Administration de nucléases spécifiques à une cible
EP3541932A4 (fr) Inhibiteurs de crispr-cas9
EP3325665A4 (fr) Procédés d'amplification de séquences d'acides nucléiques
EP3631054A4 (fr) Amplification de marquage d'extrémité multiplex d'acides nucléiques
EP3504327A4 (fr) Nucléases spécifiques de cible spécifiquement modifiées
EP3483284A4 (fr) Nanovésicules dérivées de bactéries du genrepropionibacterium
EP3507379A4 (fr) Procédés d'amplification numérique du génome entier
EP3377059A4 (fr) Inhibiteurs de cxcr2
EP3436605A4 (fr) Amplification de séquences cibles
EP3259246A4 (fr) Dérivés de sobétirome
EP3248980A4 (fr) Inhibiteur de jak
EP3565901A4 (fr) Amplification par exclusion cinétique de bibliothèques d'acide nucléique
EP3122897A4 (fr) Détection de séquences d'acides nucléiques cibles à l'aide de différentes températures de détection
EP3720606A4 (fr) Amplification de séquences d'arnm codant des protéines appariées
EP3509581A4 (fr) Formulations de (r
EP3349608A4 (fr) Article chaussant
EP3244725A4 (fr) Croissance de graines germées dans des conditions cryogéniques
EP3512567A4 (fr) Expression spécifique à une cellule d'arnmod
PL3504506T3 (pl) Cel
EP3290418A4 (fr) Inhibiteurs de jak
EP3457851A4 (fr) Dérivés de sobétirome
EP3222717A4 (fr) Procédé d'amplification d'adn circulaire
EP3048184A4 (fr) Cible de pulvérisation faite d'un alliage fritté à base de sb-te
EP3638808A4 (fr) Détection de régions de séquence ciblées

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20181029

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20190723

RIC1 Information provided on ipc code assigned before grant

Ipc: C12Q 1/6844 20180101ALI20190717BHEP

Ipc: C12Q 1/68 20180101AFI20190717BHEP

Ipc: C12Q 1/686 20180101ALI20190717BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20201112

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: REVVITY HOLDINGS, INC.